British Patient Capital and Mubadala invest in SV Biotech Crossover Opportunities Fund
British Patient Capital and Abu Dhabi-based sovereign investor Mubadala Investment Company have announced their investment into the SV Biotech Crossover Opportunities Fund (SV BCOF).